PHOENIX BIOTECH ACQUISITION (PBAXU)
Institutional ownership reported to the SEC as of Q4 2023, across 9 quarters.
3
Reporting holders
$8.4K
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CLEAR STREET LLC | $3.7K | 342 | 0.00% | 2q | HELD |
| Pineridge Advisors LLC | $2.9K | 300 | 0.00% | new | FIRST |
| Tower Research Capital LLC (TRC) | $1.9K | 175 | 0.00% | 9q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2023 | 3 | $8.4K | 817 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 2 | $5.6K | 517 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $1.8K | 175 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 2 | $1.1M | 100,175 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 3 | $1.0M | 110,422 | 0 | 0 | 1 | 0.0% |
| Q3 2022 | 20 | $21.1M | 2,093,705 | 3 | 2 | 3 | 0.0% |
| Q2 2022 | 26 | $29.1M | 2,891,675 | 2 | 2 | 6 | 0.0% |
| Q1 2022 | 27 | $32.6M | 3,227,844 | 1 | 1 | 7 | 0.0% |
| Q4 2021 | 37 | $65.5M | 6,494,295 | 33 | 0 | 0 | 0.0% |